PAIN TRIGGERS
Medication combinations fix anxiety/emotional regulation but destroy motivation, energy, and task initiation.
Timing of Guanfacine administration causes severe morning grogginess or sleep disruption if taken incorrectly.
SaaS· ADHD patientsPain 7.00/10WTP 6.0/10Market 7.0/10Validation 8.0Confidence 88%Jul 21, 2026
DoseTuning: Neurodivergent Medication & Mood Timing Tracker
Patients on combined ADHD therapies (e.g., Vyvanse + Guanfacine) experience conflicting side effects—where stimulants cause anxiety/anger and non-stimulants destroy task motivation or disrupt sleep—making optimal dose timing extremely hard to pinpoint.
adhdanalyticshealthcaremobile-appproductivitysaaswellnessworkflow
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Patients managing ADHD and anxiety struggle to find the right combination and timing of stimulant and non-stimulant medications without suffering severe side effects like loss of motivation, physical sickness, insomnia, or intense emotional volatility.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Guanfacine help!
ADHD13
Guanfacine help!
ADHD13
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD patientsA D H D Combination Therapy Patients
Patients actively adjusting doses and timing of multi-medication regimens trying to balance focus against anxiety, emotional blunting, and fatigue.
Context
Find a balanced ADHD medication regimen and dosing schedule that controls anxiety and emotional volatility without draining energy, motivation, and the ability to initiate tasks.
Alternative therapies and holistic practices to soothe the nervous system when medication doses fail or cause side effects.
Peer crowdsourcing on Reddit to decipher complex medication interactions, dosage timing, and trial-and-error adjustments.
Current Workarounds
Crowdsourcing dosage advice and timing tips on Reddit subreddits
Keeping manual notes or spreadsheets of medication timing and side effects
Self-adjusting dose timing trial-and-error without structured logging
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Higher Guanfacine doses (4mg) regulate anxiety and emotional control but severely impair energy, motivation, task initiation, and social fluency.
Vyvanse alone causes extreme irritability, anger, and anxiety driven by urgency/adrenaline, requiring non-stimulants to blunt the nervous system.
Finding an optimal dosage and timing balance is difficult, as lower stimulant doses (30mg) combined with Guanfacine result in frequent unproductive 'nothing days' and physical crash symptoms.
OPPORTUNITY & VALUE
Why Now
Repeated complaints about combination therapies resolving emotional volatility/anxiety while destroying motivation, task initiation, and energy, combined with dosing timing confusion.
Value Proposition
Unlike generic habit trackers or medication reminders, DoseTuning specifically analyzes interactions and timing offsets between stimulants and alpha-2 agonists to solve task initiation and energy crashes.
Product Direction
A specialized mobile tracking app designed for neurodivergent regimens that maps medication dosage timing against daily motivation, anxiety, energy, and sleep metrics, generating actionable timing reports for doctor consultations.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$9.99/moIndividual subscription · Includes exportable psychiatrist reports
Model
SaaS subscription
WILLINGNESS TO PAY
Patients spend months in unproductive trial-and-error and waste expensive specialist visits trying to balance their medication; paying $10/mo to accelerate reaching stability is an easy ROI.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Find your optimal ADHD medication timing without sacrificing your drive.”
A specialized mobile tracking app designed for neurodivergent regimens that maps medication dosage timing against daily motivation, anxiety, energy, and sleep metrics, generating actionable timing reports for doctor consultations.
Core Features
Multi-medication dose and timestamp logger
1-tap friction-free daily mood, energy, and task initiation check-ins
Visual overlay charts mapping peak concentration curves against reported side effects
PDF export summary for psychiatrist and prescribing physician visits
Weekly Roadmap
1
W1-W2
Core logging framework for multi-medication timestamps and basic mood check-ins.
- •Build local database schema for medication logs and symptom timestamps
- •Design minimal 1-tap logging interface tailored for low executive function
- •Implement local push notifications for dose and side-effect check-ins
2
W3-W4
Visualization dashboard mapping medication overlap against daily energy and motivation.
- •Develop overlay chart correlating dose timing with reported motivation and grogginess
- •Build physician summary report generator (PDF export)
- •Add custom symptom tags (task initiation, anger, morning grogginess)
3
W5
In-app subscription integration and beta testing with ADHD communities.
- •Integrate RevenueCat for Apple/Google in-app subscriptions
- •Recruit 20 ADHD beta testers from r/VyvanseADHD for dogfooding
- •Refine UI friction based on daily logging completion rates
4
W6
Public launch on App Store and Play Store with community launch.
- •Publish iOS and Android builds to store storefronts
- •Launch organic content campaign targeting neurodivergent medication management on X/TikTok
- •Track conversion from free trial to paid subscriber
Launch Strategy
Target ADHD patient communities across Reddit (r/ADHD, r/VyvanseADHD) and neurodivergent content creators on TikTok/X with educational content on medication crash timing.
RISKS & ASSUMPTIONS
Top Risks
Adoption barrier due to executive dysfunction
Target users suffer from severe task initiation challenges and may forget or abandon logging their symptoms daily.
Medical disclaimer & liability boundaries
App must carefully position itself as a self-tracking tool rather than giving clinical medical advice.
Short user lifecycle
Users may churn once they successfully optimize their medication timing and reach steady-state balance.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "analytics", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "DoseTuning: Neurodivergent Medication & Mood Timing Tracker" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.